Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Idexx Laboratories, Inc shares valued at $1,415,700 were sold by SZOSTAK M ANNE on Aug 22 ’25. At $647.33 per share, SZOSTAK M ANNE sold 2,187 shares. The insider’s holdings dropped to 262 shares worth approximately $0.17 million following the completion of this transaction.
Also, MARGARET ANNE SZOSTAK purchased 2,187 shares, netting a total of over 1,415,700 in proceeds.
Before that, Erickson Michael G had sold 406 shares from its account. In a trade valued at $263,813, the Executive Vice President traded Idexx Laboratories, Inc shares for $649.96 each. Upon closing the transaction, the insider’s holdings decreased to 406 shares, worth approximately $7.11 million.
As published in their initiating research note from UBS on October 01, 2025, Idexx Laboratories, Inc [IDXX] has been a Neutral and the price target has been revised to $720. Analysts at BTIG Research resumed the stock at ‘”a Buy”‘ outlook in a report released in early August. As of July 01, 2025, Jefferies has initiated its “Buy” rating for IDXX. Earlier on December 02, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for IDXX stock.
Analyzing IDXX Stock Performance
On last trading session, Idexx Laboratories, Inc [NASDAQ: IDXX] rose 0.42% to $629.91. The stock’s lowest price that day was $626.64, but it reached a high of $638.629 in the same session. During the last five days, there has been a surge of approximately 1.58%. Over the course of the year, Idexx Laboratories, Inc shares have jumped approximately 31.87%. Shares of the company reached a 52-week high of $688.12 on 08/04/25 and a 52-week low of $356.14 on 04/09/25.
Support And Resistance Levels for Idexx Laboratories, Inc (IDXX)
According to the 24-hour chart, there is a support level at 624.47, which, if violated, would cause prices to drop to 619.03. In the upper region, resistance lies at 636.99. The next price resistance is at 644.07. RSI (Relative Strength Index) is 48.31 on the 14-day chart, showing neutral technical sentiment.
Is Idexx Laboratories, Inc subject to short interest?
Stocks of Idexx Laboratories, Inc saw a sharp rise in short interest on 2025-09-15 jumping by 0.29 million shares to 2.12 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 1.83 million shares. A jump of 13.63% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.41 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.41.
Which companies own the most shares of Idexx Laboratories, Inc (IDXX)?
In terms of Idexx Laboratories, Inc share price expectations, FactSet research, analysts set an average price target of 721 in the next 12 months, up nearly 14.94% from the previous closing price of $627.28. Analysts anticipate Idexx Laboratories, Inc stock to reach 785 by 2025, with the lowest price target being 640. In spite of this, 6 analysts ranked Idexx Laboratories, Inc stock as Buy at the end of 2025. On July 25, 2024, BTIG Research assigned a price target of “a Buy” to the stock and initiated coverage with a $580.
